Susan Berland
Director/Board Member en SENTI BIOSCIENCES, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Ms. Susan D.
Berland is an Independent Director at Senti Biosciences, Inc. She is on the Board of Directors at Senti Sub I, Inc. and Senti Biosciences, Inc. Ms. Berland was previously employed as a Chief Financial Officer by Atreca, Inc., a Chief Financial Officer by Mendel Biotechnology, Inc., a Chief Financial Officer by Poniard Pharmaceuticals, Inc., a Chief Financial Officer by DNA Sciences, Inc., a Chief Financial Officer by Bluestar Genomics, Inc., a Head-Financial Planning by Monsanto Co., and a Co-Founder by Veracyte, Inc. She received her undergraduate degree from the University of Wisconsin-Milwaukee and an MBA from the University of Wisconsin-Milwaukee.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SENTI BIOSCIENCES, INC.
-.--% | 16/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Susan Berland
| Empresas | Cargo | Inicio |
|---|---|---|
| SENTI BIOSCIENCES, INC. | Director/Board Member | 01/06/2021 |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Director/Board Member | 01/06/2021 |
Antiguos cargos conocidos de Susan Berland.
| Empresas | Cargo | Fin |
|---|---|---|
| ATRECA, INC. | Director of Finance/CFO | 25/02/2019 |
Mendel Biotechnology, Inc.
 Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | Director of Finance/CFO | 01/12/2014 |
| PONIARD PHARMACEUTICALS, INC. | Director of Finance/CFO | 21/07/2006 |
DNA Sciences, Inc.
 DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a private company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Director of Finance/CFO | 01/05/2003 |
| MONSANTO | Corporate Officer/Principal | 01/08/2000 |
Formación de Susan Berland.
| University of Wisconsin-Milwaukee | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| VERACYTE, INC. | Health Technology |
| ATRECA, INC. | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
DNA Sciences, Inc.
DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a private company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Health Technology |
Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | Commercial Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
ClearNote Health, Inc.
 ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology ClearNote Health, Inc. is a company that develops liquid biopsy tests to detect cancers with high mortality rates early when they respond best to treatment. ClearNote Health is based in San Mateo, CA. The company uses its proprietary epigenomics platform to analyze individuals' changing biology that is yet to produce symptoms. The company was founded by Stephen D. Quake, and David Mullarkey has been the CEO of the company since 2022. | Health Technology |
- Bolsa de valores
- Insiders
- Susan Berland
